| Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Research Abstract |
To reveal the mechanisms of progression of chronic kidney diseases, the roles of TRPC6, which was reported to be a causative gene for one type of congenital focal segmental sclerosis and related some forms of renal diseases, and NFAT and NFκB, TRPC6-related signal transduction protein, were examined in the rat models of renal diseases. The inhibitor of NFκB ameliorated renal impairment by aldosterone, which is recently reported to play a role in the renal injury of chronic kidney diseases, whereas TRPC6 and NFAT did not show significant changes. In the present study, it was suggested that NFκB activation plays important roles in certain types of kidney diseases and its inhibitor may be a candidate for the treatment of chronic kidney disease.
|
